Ctrl/Cmd K

Loading stock analysis…

Explore

Stocks
Screener
IPOs
News

Tools

Backtest
Portfolio
Wealth
ITR

Learn

Guides
Methodology

Company

About
Contact
Disclosures
Privacy
Terms

© 2026 Anvest. All rights reserved.

Designed & Engineered in India·harsh@anvest.in

Disclaimer: Anvest provides financial analytics, screening simulations, and planning tools for informational and educational purposes only. Anvest is not a SEBI-registered investment advisor or broker. Nothing herein constitutes investment advice or an offer to buy/sell securities. Full details on methodology and limitations are documented under Disclosures and Terms.

Stocks›Healthcare

Abbott India Limited

ABBOTINDIA · NSE · Healthcare · As of 30 Oct 2026Delayed / Sandbox EOD Data

₹25,635.00

−₹510.00 (−1.95%)(1D)

₹24,650.0052 Week Range₹30,655.00

Chart Score AI Profile Fundamentals Technicals Financials Shareholding Peers Filings

Anvest Score

72/100

Valuation

40/100

Quality

78/100

Growth

93/100

Health

100/100

Momentum

49/100

Valuation
40
Quality
78
Growth
93
Health
100
Momentum
49

Loading company profile…

Loading fundamentals…

Loading technical indicators…

Loading financial statement…

Loading shareholding…

Loading peer comparison…

Loading filings…

More Page Context

Research at a glance

Abbott India Limited with delayed price, financials, ownership context, and peer links.

Latest price

₹25,635

Market cap

₹54,474 Cr

P/E ratio

35.1

P/B ratio

Not available

Dividend yield

Not available

ROE

Not available

RSI 14

45.54

1Y return

Not available

Abbott India Limited FAQs

3 topics

ExpandCollapse

Related paths

Peer links appear when comparable names are available.

Open screener Curated screens Backtest ideas

What does the Abbott India Limited (ABBOTINDIA) stock page cover?

Abbott India Limited on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.

What are the current headline metrics for ABBOTINDIA?

Abbott India Limited is currently shown with a delayed price near ₹25,635, P/E 35.1.

Does the ABBOTINDIA page provide investment advice?

No. The ABBOTINDIA page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.

Keep exploring

Related insights

ALKEM

Alkem Laboratories Limited · Healthcare

GLAND

Gland Pharma Limited · Healthcare

IPCALAB

IPCA Laboratories Limited · Healthcare

Eliminating Look-Ahead Bias in Indian Fundamental Backtests

Understand why using quarter-end dates (like March 31) invalidates fundamental backtests. Learn how Anvest enforces official SEBI filing delays.

AI Company ProfileSign in to generate AI briefing

AI Snapshot

Abbott India Limited operates in Drug Manufacturers - Specialty & Generic within the Healthcare sector. The company operates primarily within the Pharmaceuticals segment, focusing on therapeutic areas like women's health, gastroenterology, cardiology, metabolic disorders, primary care, neurology, and vaccines.

Drug Manufacturers - Specialty & GenericFounded:1944CEO/MD:Vivek V KamathHQ:Mumbai, Maharashtra

Business at a Glance

Abbott India generates revenue by developing, manufacturing, and marketing a diverse portfolio of pharmaceutical products, including branded generics and patented drugs, to patients and healthcare providers across India.

What Looks Strong

Financial highlights are being recalculated.

What to Watch

Financial highlights are being recalculated.

It leverages its parent company's global research and development capabilities and strong brand reputation to drive sales in the Indian market.
Its operations are geographically concentrated within India.